Test Price
2,800 AED✅ Home Collection Available
DIABLO Gene (Autosomal Dominant Deafness 64) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين DIABLO للصمم الوراثي السائد من النوع 64 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – Your Trusted Diagnostic Partner in the UAE
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance on result interpretation by DHA-licensed specialists.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ضمان دقة التشخيص بنسبة 99.9% وفقاً لمعايير الأيزو ودليل هيئة الصحة بدبي.
Overview
This Next‑Generation Sequencing test targets the DIABLO gene to confirm autosomal dominant nonsyndromic hearing loss type 64 (DFNA64), enabling precise genetic diagnosis and informed family planning. In the UAE, يؤكد التحليل وجود طفرات جين DIABLO accurately within 3‑4 weeks using whole blood, extracted DNA, or a dried blood spot on an FTA card.
| Feature | Our DIABLO NGS Test | Closest Alternative (Single‑Gene Sanger Sequencing) |
|---|---|---|
| Diagnostic Precision | 99.9% Sensitivity; detects all variant types (SNVs, indels, CNVs) across the entire DIABLO gene | 90‑95% for point mutations only; misses large deletions/duplications |
| Methodology | NGS (Illumina NovaSeq, clinically validated bioinformatics pipeline) | Sanger sequencing, limited to a single exon‑by‑exon approach |
| Turnaround Time | 3 – 4 weeks from sample receipt | 5 – 8 weeks |
Physician Insight & Safety Protocol
“This test offers definitive molecular confirmation of autosomal dominant deafness 64. It is crucial to correlate genetic findings with audiometric and clinical evaluation. Remember, a negative result does not exclude other genetic or environmental causes of hearing loss.” – Dr. Prabhakar Reddy, DHA License 61713011.
Do not discontinue prescribed medication without consulting your doctor.
Safety & Exclusion Criteria
- This test is not intended for acute sudden hearing loss, acute ear infection, or vestibular emergencies.
- Minors must be accompanied by a legal guardian; compliance with 2026 CDS Law is mandatory.
- If you experience sudden hearing loss with dizziness, vertigo, tinnitus, or facial weakness, seek emergency medical care immediately.
- Individuals on anticoagulant therapy: a standard blood draw is generally safe; however, inform the phlebotomist of all medications.
Patient FAQ & Clinical Guidance
Q: What is the DIABLO gene test and who should consider it?
A: This test analyzes the DIABLO gene to confirm autosomal dominant deafness type 64, particularly for individuals with a family history of early-onset hearing loss. It is recommended for children and adults exhibiting progressive sensorineural hearing loss, as well as asymptomatic relatives seeking carrier status and reproductive risk assessment.
س: ما هو تحليل جين DIABLO ومن يجب عليه إجراءه؟
ج: يحلل هذا الفحص جين DIABLO لتأكيد الصمم الوراثي السائد من النوع 64، وينصح به لمن لديهم تاريخ عائلي لفقدان السمع المبكر أو ضعف سمع حسي عصبي مترقي.
Q: How is the sample collected and what is the turnaround time?
A: A certified phlebotomist collects a simple blood sample, extracted DNA, or a single drop of blood on an FTA card during your home visit; results are delivered in 3 to 4 weeks. All specimens are transported under ISO‑certified cold‑chain logistics.
س: كيف يتم جمع العينة وكم تستغرق النتيجة؟
ج: يجمع اختصاصي سحب الدم عينة دم بسيطة أو بقعة دم على بطاقة FTA خلال زيارة منزلية، وتصدر النتائج خلال 3 إلى 4 أسابيع عبر سلسلة تبريد معتمدة.
Q: Do any medications or supplements affect the test result?
A: No routine drugs interfere with the NGS genetic analysis; nonetheless, inform the pre‑test counselor about all prescription medications, over‑the‑counter supplements, and herbal products. Continue all prescribed treatments unless your physician advises otherwise.
س: هل تؤثر الأدوية أو المكملات على نتيجة التحليل؟
ج: لا تؤثر الأدوية الروتينية على تحليل التسلسل الجيني؛ مع ذلك، أبلغ مستشار الوراثة عن جميع الأدوية والمكملات، ولا تتوقف عن دوائك دون استشارة الطبيب.
Pre‑Test Information
- Submit a detailed clinical history of hearing loss, including age of onset, audiogram results, and family pedigree.
- A pre‑ genetic counselling session (provided at no extra cost) is strongly recommended to draw a pedigree chart of family members affected with autosomal dominant deafness.
- No fasting required; continue prescribed medications unless instructed otherwise.
- Acceptable sample types: 3‑5 mL whole blood (EDTA tube), extracted DNA (minimum 1 µg), or one drop of blood on an FTA card.
UAE Regulatory & Data Privacy Compliance
All testing is conducted in strict accordance with Federal Decree‑Law No. 41 of 2024 on Medical Liability (Art. 87), the 2026 Control of Communicable Diseases Law (Minors’ consent provisions), and the UAE Personal Data Protection Law (PDPL). Your genetic data is stored on secure, UAE‑based servers with end‑to‑end encryption. Laboratory license: 9834453. ISO 9001:2015 Certificate INT/EGQ/2509DA/3139.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians